drugset / Trial / NCT01430806

Dronaderone to Prevent Recurrent Implantable Cardioverter Defibrillator (ICD) Shocks

NCT01430806

Unknown 20 enrolled Rabin Medical Center
Non-randomizedSingle-groupOpen-labelTreatment

Summary

Recurrent ICD shocks are a serious problem in pts with ICD. Treatment failure with other antiarrhythmics and ablation are common. Dronedarone is a new antiarrhythmic drug with ion channel properties similar to amiodarone. Several case reports have shown promising results with Dronedarone for this patient population.

Timeline

Start
2011-10
Primary completion
2014-12
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Dronedarone Small molecule 400 mg Oral

Indications

No indication recorded.